Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma

Archives of Ophthalmology

Volumn 130, Issue 5, 2012, Pages 599-606

  Yousef, Yacoub A ^a   Finger, Paul T ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; DISEASE SEVERITY; FOLLOW UP; HUMAN; MELANOMA; METASTASIS; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR RECURRENCE; TUMOR VOLUME;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; AGED; AGED, 80 AND OVER; CHILD; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MEDICAL ONCOLOGY; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84860900944     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.2566     Document Type: Article

References (32)

1. Seregard S. Conjunctival melanoma. Surv Ophthalmol. 1998;42(4):321-350. (Pubitemid 28092772)
2. Tuomaala S, Eskelin S, Tarkkanen A, Kivelä T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002;43(11):3399-3408. (Pubitemid 35334346)
3. Yu GP, Hu DN, McCormick S, Finger PT. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;135(6):800-806. (Pubitemid 36677397)
4. Triay E, Bergman L, Nilsson B, All-Ericsson C, Seregard S. Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol. 2009;93(11):1524-1528.
5. Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci. 2005;46(1):75-82. (Pubitemid 40041181)
6. Desjardins L, Poncet P, Levy C, Schlienger P, Asselain B, Validire P. Prognostic factors in malignant melanoma of the conjunctiva: an anatomo-clinical study of 56 patients. J Fr Ophtalmol. 1999;22(3):315-321. (Pubitemid 29206942)
7. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol. 2002;86(2):163-167. (Pubitemid 34127540)
8. Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol. 2002;25(3):248-255. (Pubitemid 34602545)
9. Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1108-1114. (Pubitemid 43124161)
10. Lommatzsch PK, Lommatzsch RE, Kirsch I, Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol. 1990;74(10):615-619. (Pubitemid 20302797)
11. De Potter P, Shields CL, Shields JA, Menduke H. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol. 1993;77(10):624-630. (Pubitemid 23298381)
12. Jakobiec FA, Rini FJ, Fraunfelder FT, Brownstein S. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma: experience with 62 cases. Ophthalmology. 1988;95(8):1058-1070.
13. Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol. 1985;16(2):129-135. (Pubitemid 15136923)
14. Finger PT. Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Surv Ophthalmol. 2009;54(5):545-568.
15. McDonnell JM, Carpenter JD, Jacobs P, Wan WL, Gilmore JE. Conjunctival melanocytic lesions in children. Ophthalmology. 1989;96(7):986-993. (Pubitemid 19182140)
16. Robertson DM, Hungerford JL, McCartney A. Malignant melanomas of the conjunctiva, nasal cavity, and paranasal sinuses. Am J Ophthalmol. 1989;108(4):440-442. (Pubitemid 19259210)
17. Finger PT. "Finger-tip" cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia. Br J Ophthalmol. 2005;89(8):942-945. (Pubitemid 41081399)
18. Shields CL, Demirci H, Karatza E, Shields JA. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004;111(9):1747-1754. (Pubitemid 39179692)
19. Wilson MW, Czechonska G, Finger PT, Rausen A, Hooper ME, Haik BG. Chemotherapy for eye cancer. Surv Ophthalmol. 2001;45(5):416-444. (Pubitemid 32239519)
20. Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology. 1989;96(2):147-166. (Pubitemid 19049454)
21. Damato B, Coupland SE. Clinical mapping of conjunctival melanomas. Br J Ophthalmol. 2008;92(11):1545-1549.
22. AJCC-UICC Ophthalmic Oncology Task Force. Malignant melanoma of the conjunctiva. In: Edge SE, Byrd DR, Carducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009:539-546.
23. Finger PT, Tran HV, Turbin RE, et al. High-frequency ultrasonographic evaluation of conjunctival intraepithelial neoplasia and squamous cell carcinoma. Arch Ophthalmol. 2003;121(2):168-172. (Pubitemid 36184028)
24. Finger PT, Milner MS, McCormick SA. Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol. 1993;77(11):751-753. (Pubitemid 23326071)
25. Finger PT. Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia. Br J Ophthalmol. 2006;90(7):807-809.
26. Finger PT, Sedeek RW, Chin KJ. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol. 2008;145(1):124-129.
27. Tuomaala S, Kivelä T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology. 2004;111(4):816-821. (Pubitemid 38429682)
28. Paridaens ADA, McCartney ACE, Minassian DC, Hungerford JL. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol. 1994;78(7):520-528. (Pubitemid 24213009)
29. Shields CL, Shields JA, Gündüz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000;118(11):1497-1507.
30. Savar A, Esmaeli B, Ho H, Liu S, Prieto VG. Conjunctival melanoma: localregional control rates, and impact of high-risk histopathologic features. J Cutan Pathol. 2011;38(1):18-24.
31. Damato B, Coupland SE. Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Experiment Ophthalmol. 2008;36(8):786-795.
32. Stefani FH. A prognostic index for patients with malignant melanoma of the conjunctiva. Graefes Arch Clin Exp Ophthalmol. 1986;224(6):580-582.